10:55 AM EDT, 07/18/2024 (MT Newswires) -- Bristol Myers Squibb ( BMY ) said Thursday it has validated its near-term and longer-term targets to lower greenhouse emissions throughout its value chain to net-zero by 2050 through the Science Based Targets initiative.

The drug maker announced its net-zero goal last year and also set several interim targets, including reducing its direct and indirect emissions, by at least 54.6% by 2033. As part of those efforts, the company expects to obtain all of its purchased electricity from renewable sources by 2030.

It is also working to reduce emissions throughout its value chain, with roughly half of Bristol Myers' suppliers either committing or already working to lower their emissions, the company said.

Price: 43.64, Change: +0.49, Percent Change: +1.14